A randomised controlled clinical study of standard triple therapy, bismuth-based quadruple therapy and sequential therapy for Helicobacter pylori infection in children
The three therapeutic regimens evaluated in this study are equally not recommendable for H. pylori infection treatment due to unsatisfactory eradication rates. The high prevalence of clarithromycin resistance makes the use of clarithromycin-based quadruple therapy not advisable, even in combination with amoxicillin and bismuth salts.
Authors
- Zhiling Wang
- Shan Gao (ORCID: https://orcid.org/0000-0003-4832-5739)
- Ruixue Miao
- Jing Chen (ORCID: https://orcid.org/0000-0002-5763-6902)
- Chaomin Wan (ORCID: https://orcid.org/0000-0003-1480-3050)
- Liyuan Wang (ORCID: https://orcid.org/0000-0003-2718-6450)
- Wei Zhou (ORCID: https://orcid.org/0000-0002-3139-989X)
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1186/s12887-024-05020-6
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Sichuan University